What is FemTech, you ask? It is a sub-sector of life sciences and technology that brings the spotlight to companies […]
The Current State of FemTech and Upcoming Market Trends

What is FemTech, you ask? It is a sub-sector of life sciences and technology that brings the spotlight to companies […]
Join us for a live webinar on how to modernize B2B healthcare marketing. As the business needs and industry landscape […]
Healthcare technology solutions are popping up everywhere. AI, ML, and other automation solutions are more prevalent than ever. How your […]
Join Marc Samuels and Lindsay Bealor Greenleaf, from ADVI Health. Two of Washington, DC’s most prominent health and life science policy […]
Tamir Meiri will cover how Johnson & Johnson Venture Investments invests and supports globally to bring strategic value to companies […]
Jared Sorin, co-leader of the Emerging Companies and Venture Capital practice group & Adam Schoen, Partner at Brown Rudnick, will […]
Healthcare organizations from all corners are competing to leverage flexible technology infrastructure to rapidly push out offerings that meet consumer […]
Developing software for medical devices is vastly different than developing other commercial software. In this talk, we will explore how software […]
Interested in what makes a product salable and approvable? Interested in an insider’s view on what gets your device approved at FDA? Or how to navigate the regulations and use them to your advantage? How will recent developments to the United States Food and Drug Administration regulations impact your healthtech business? Whether you’re a CEO, entrepreneur, investor, clinician, or a professional in the general industry, join us as Neil Di Spirito gives us an insider’s perspective and breaks down what digital health and device companies should know about FDA regulations.